Sunesis Pharmaceuticals (SNSS) Misses Q1 EPS by 12c
Tweet Send to a FriendGet Alerts SNSS Hot Sheet
Price: $5.46 +0.92%
EPS Growth %: +23.3%
Financial Fact:
License and other revenue: 1.99M
Today's EPS Names:
LBIX, ESEA, ISS, More
EPS Growth %: +23.3%
Financial Fact:
License and other revenue: 1.99M
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade SNSS Now!
Sunesis Pharmaceuticals (NASDAQ: SNSS) reported Q1 EPS of ($0.30), $0.12 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $0 versus the consensus estimate of $90 thousand.
For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Orient Paper, Inc. (ONP) Reports Q1 EPS of $0.02; Guides FY13
- Wal-mart (WMT) Posts Q1 EPS of $1.14; U.S. Comps Down 1.4%; Guides Q2 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
